Riskpilot← Back to searchSign inGet full accessTreat4Life AB
ABActiveOrg 5590000302Föreningsgatan 83 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20151 employees
Revenue 2024
SEK 451K
EBITDA margin
-226.9%
-131% vs 2023
Equity ratio
20.6%
Financial strength
Net profit 2024
SEK -1,2M
-153% vs 2023
| Revenue | SEK 451K | — |
| EBITDA | SEK -1M | -131% |
| Net profit | SEK -1,2M | -153% |
| Total assets | SEK 322K | -81% |
| Equity | SEK 66K | -88% |
| Employees | 1 | — |
Legal name
Treat4Life AB
Org number
5590000302
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12 januari 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva medicinsk forskning och därmed förenlig verksamhet.
Address
Föreningsgatan 83 A
Email
roger@t4l.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 474 | 922 | 0 | 451 |
| Staff expenses | — | — | −1 329 | −1 353 | −366 |
| EBITDA | −6 076 | −4 597 | −2 050 | −442 | −1 023 |
| Depreciation & amort. | −943 | −876 | −356 | −26 | −17 |
| EBIT | −7 019 | −5 473 | −2 406 | −468 | −1 183 |
| Net financials | 3 | — | −0 | 1 | −0 |
| Profit before tax | −7 015 | −5 473 | −2 406 | −468 | −1 184 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −7 015 | −5 473 | −2 406 | −468 | −1 184 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 649 | 1 153 | 1 887 | 1 664 | 322 |
| Equity | 697 | 424 | 518 | 550 | 66 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 952 | 729 | 1 369 | 1 114 | 256 |
| Total debt | 952 | 729 | 1 369 | 1 114 | 256 |
EBITDA margin
-226.9%
This company
15.8%
Market median
-1536% vs market
20202024
Equity ratio
20.6%
This company
38.2%
Market median
-46% vs market
20202024
Return on equity
-1786.3%
This company
18.4%
Market median
-9808% vs market
20202024
Net profit margin
-262.6%
This company
8.1%
Market median
-3342% vs market
20202024
Asset turnover
1.40×
This company
1.12×
Market median
+25% vs market
20202024
Debt / equity
3.87×
This company
0.62×
Market median
-524% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AM Auditor Substitute | Auditor Substitute | 2020 |
HE Chief Executive Officer | Chief Executive Officer | 2020 |
AM | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Treat4Life AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Magnus Arleborn | Auditor Substitute | 0 companies |
| Hans Erik Roger Appelqvist | Chief Executive Officer | 0 companies |
| Anette Madelein Samzelius | Audit | 0 companies |
| Bo Torsten Baldetorp | Deputy Board Member | 0 companies |
| György Marko-Varga | Board of Directors | 0 companies |
| Hans Edvard Christer Skalin | Deputy Board Member | 0 companies |
| Ture Jonas Christer Gulliksson | Chairman | 0 companies |